Tissucol®
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Femoral Vascular Anastomosis
Conditions
Femoral Vascular Anastomosis
Trial Timeline
Sep 1, 2003 → Feb 1, 2004
NCT ID
NCT00163592About Tissucol®
Tissucol® is a pre-clinical stage product being developed by Baxter for Femoral Vascular Anastomosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00163592. Target conditions include Femoral Vascular Anastomosis.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00163592 | Pre-clinical | Completed |
Competing Products
3 competing products in Femoral Vascular Anastomosis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Teriparatide 20 mcg | Eli Lilly | Phase 3 | 77 |
| zoledronic acid (aclasta) | Novartis | Phase 3 | 77 |
| Tranexamic Acid plus standard of care | Pfizer | Approved | 84 |